Bioventus’ international sales team came together in Sintra, Portugal for its fun and inspiring annual meeting. Setting the stage with our 2025 theme "Owning Our Future: What Comes Next Is What Matters,” we enjoyed three days of creating connections, building knowledge, and celebrating accomplishments with our colleagues. In addition, we were honored to host two outstanding guest speakers: Paul Harwood, MD, an orthopaedic trauma and limb reconstruction surgeon based in Leeds, England, brought a clinician’s perspective to a discussion about the impact of nonunions on patients and on healthcare systems; and Bharat R. Dave, MD, a spine surgeon in Ahmedabad, India, led an engaging session and hands-on workshop about the use of ultrasonic instruments in spine surgery. On the last evening, we gathered for an awards gala to recognize our highest-achieving sales professionals, at Sintra’s gorgeous Casa dos Penedos. #BioventusCares -- EXOGEN is indicated for the non-invasive treatment of osseous defects (excluding vertebra and skull) created by trauma or as a result of surgical orthopedic procedure. There are no known contraindications. Patients may experience sensitivity to the ultrasound gel. See full prescribing information at EXOGEN.com
-
-
-
-
-
+7